speb/financial-data huggingface dataset:
Financial ratios for RCM.AX — annual report dated 2024-12-31
Operating income: -8971775.155279502
Net income: -12763919.254658384
Capital expenditures: 346760.86956521735
Depreciation & amortization: 6160.869565217391
Net tangible assets: -7301187.577639751
Owner earnings: -13104519.254658384
Buffett classification: The Gruesome
Stock price: 0.03726708074534161
Shares outstanding: 1196026888
Book value: -6559501.242236025
Market cap (USD): 44572430.60869565
Debt to equity: -1.6351964723874532
Current ratio: 0.030069055916600914
Quick ratio: 0.030069055916600914
Interest coverage ratio: -2.3605609367750695
Free cash flow (dilution-adjusted): -1521184.4720496894
Buyback yield (%): 0.20440733324606214
Retained earnings: -26944600
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.75
Shares outstanding: 238825345
Market cap (USD): 1612071078.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDW — annual report dated 2022-12-31
Total revenue: 160549000
Gross profit: 28695000
Operating income: -46588000
Net income: -130617000
Capital expenditures: 3626000
Operating cash flow: -31657000
Depreciation & amortization: 11288000
Net tangible assets: -61825000
Owner earnings: -122955000
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 238825345
Book value: 69890000
P/B ratio: 6.765977723565603
Market cap (USD): 472874183.1
Debt to equity: 1.3604950636714837
Current ratio: 1.0150729900041167
Quick ratio: 0.9995672320797138
Interest coverage ratio: -5.668329480472077
COGS to revenue (%): 82.1269518963058
R&D to revenue (%): 3.07756510473438
SG&A to revenue (%): 43.81341521902971
Free cash flow (dilution-adjusted): -46595000
Buyback yield (%): 0
Retained earnings: -206528000
Inventory turnover: 89.75765827093261
Receivables turnover: 2.7465400735608587
Capitalized R&D asset: 4941000
ROCI (R&D-adjusted, %): -25.785586658725435
FCF margin (%): -29.022292259683958
Rule of 40 score: -29.022292259683958
Financial ratios for RDW — annual report dated 2023-12-31
Total revenue: 243800000
Gross profit: 57969000
Operating income: -15535000
Net income: -27263000
Capital expenditures: 5620000
Operating cash flow: 1231000
Depreciation & amortization: 10724000
Net tangible assets: -76145000
Owner earnings: -22159000
Buffett classification: The Gruesome
Stock price: 2.85
Shares outstanding: 238825345
Book value: 52825000
P/B ratio: 12.885039910080454
Market cap (USD): 680652233.25
Debt to equity: 2.00350212967345
Current ratio: 0.9756953122210718
Quick ratio: 0.9621639473026528
Interest coverage ratio: -1.4520048602673148
COGS to revenue (%): 76.22272354388843
R&D to revenue (%): 2.042247744052502
SG&A to revenue (%): 28.107054963084494
Free cash flow (dilution-adjusted): -15754000
Buyback yield (%): 0
Retained earnings: -233791000
Inventory turnover: 122.57981530343008
Receivables turnover: 3.482459147525997
Capitalized R&D asset: 8289470
ROCI (R&D-adjusted, %): -8.275108805801793
Rosenberg metric: 5.924711596842744
FCF margin (%): -6.4618539786710425
Revenue growth (%): 51.85395113018455
Rule of 40 score: 45.392097151513504
Financial ratios for RDW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.87
Shares outstanding: 238825345
Market cap (USD): 1640730120.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.46
Shares outstanding: 238825345
Market cap (USD): 3931065178.7000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDW — annual report dated 2024-12-31
Total revenue: 304101000
Gross profit: 44455000
Operating income: -33071000
Net income: -114311000
Capital expenditures: 6399000
Operating cash flow: -17348000
Depreciation & amortization: 11692000
Net tangible assets: -184858000
Owner earnings: -109018000
Buffett classification: The Gruesome
Stock price: 16.46
Shares outstanding: 238825345
Book value: -51909000
Market cap (USD): 3931065178.7000003
Debt to equity: -2.792983875628504
Current ratio: 0.8431931861553604
Quick ratio: 0.828200853069779
Interest coverage ratio: -2.452792405251057
COGS to revenue (%): 85.38150154060658
R&D to revenue (%): 2.015119976586726
SG&A to revenue (%): 23.47838382642609
Free cash flow (dilution-adjusted): -39590000
Buyback yield (%): 0
Retained earnings: -348106000
Inventory turnover: 115.96516301920501
Receivables turnover: 4.682150610478991
Capitalized R&D asset: 11094460
ROCI (R&D-adjusted, %): -20.918996881444134
Rosenberg metric: -2.714199638481623
FCF margin (%): -13.018701023673056
Revenue growth (%): 24.733798195242002
Rule of 40 score: 11.715097171568946
Financial ratios for RDW — quarterly report dated 2025-03-31
Total revenue: 61395000
Gross profit: 9041000
Operating income: -10518000
Net income: -2948000
Capital expenditures: 1790000
Operating cash flow: -45081000
Depreciation & amortization: 3046000
Net tangible assets: -67396000
Owner earnings: -1692000
Buffett classification: The Gruesome
Stock price: 8.29
Shares outstanding: 238825345
Book value: 66670000
P/B ratio: 29.696446828408575
Market cap (USD): 1979862110.0499997
Debt to equity: 1.8809809509524524
Current ratio: 1.1990265053736229
Quick ratio: 1.180535168969648
Interest coverage ratio: -2.9265442404006676
COGS to revenue (%): 85.2740451176806
R&D to revenue (%): 1.3242120693867578
SG&A to revenue (%): 30.53343106116133
Free cash flow (dilution-adjusted): -52048000
Buyback yield (%): 0
Retained earnings: -351054000
Inventory turnover: 23.884124087591243
Receivables turnover: 0.8077864322930373
Capitalized R&D asset: 813000
ROCI (R&D-adjusted, %): -5.080205734073433
FCF margin (%): -84.77563319488559
Rule of 40 score: -84.77563319488559
Financial ratios for RDW — quarterly report dated 2025-06-30
Total revenue: 61760000
Gross profit: -19064000
Operating income: -75248000
Net income: -96979000
Capital expenditures: 2962000
Operating cash flow: -87663000
Depreciation & amortization: 5060000
Net tangible assets: -125899000
Owner earnings: -94881000
Buffett classification: The Gruesome
Stock price: 16.3
Shares outstanding: 238825345
Book value: 1059485000
P/B ratio: 3.6742880961032953
Market cap (USD): 3892853123.5
Debt to equity: 0.2193669565873986
Current ratio: 1.4604518930412294
Quick ratio: 1.1090492089184072
Interest coverage ratio: -3.1676699642180592
COGS to revenue (%): 130.8678756476684
R&D to revenue (%): 2.7849740932642484
SG&A to revenue (%): 88.18652849740933
Free cash flow (dilution-adjusted): -126232000
Buyback yield (%): 0
Retained earnings: -493393000
Inventory turnover: 1.3737401206764681
Receivables turnover: 0.7029764953616755
Capitalized R&D asset: 2264710
ROCI (R&D-adjusted, %): -5.53768660473354
Rosenberg metric: -34.56949569495695
FCF margin (%): -204.39119170984458
Revenue growth (%): 0.5945109536607216
Rule of 40 score: -203.79668075618386
Financial ratios for RDW — quarterly report dated 2025-09-30
Total revenue: 103432000
Gross profit: 16810000
Operating income: -41168000
Net income: -41152000
Capital expenditures: 6536000
Operating cash flow: -20325000
Depreciation & amortization: 12121000
Net tangible assets: -120327000
Owner earnings: -35567000
Buffett classification: The Gruesome
Stock price: 8.99
Shares outstanding: 238825345
Book value: 1032914000
P/B ratio: 2.078624020538012
Market cap (USD): 2147039851.55
Debt to equity: 0.22155377892060713
Current ratio: 1.408219068184705
Quick ratio: 1.050608708441693
Interest coverage ratio: -6.553326965934416
COGS to revenue (%): 83.74777631680718
R&D to revenue (%): 7.437736870600975
SG&A to revenue (%): 48.61648232655271
Free cash flow (dilution-adjusted): -39807000
Buyback yield (%): 0.11066399155491727
Retained earnings: -536289000
Inventory turnover: 1.6193752219999626
Receivables turnover: 1.2476568437051423
Capitalized R&D asset: 9113690
ROCI (R&D-adjusted, %): -2.8246448235244364
Rosenberg metric: 20.856976744186046
FCF margin (%): -38.48615515507773
Revenue growth (%): 67.47409326424871
Rule of 40 score: 28.987938109170976
Financial ratios for RDW — quarterly report dated 2025-12-31
Total revenue: 108794000
Gross profit: 10498000
Operating income: -46822000
Net income: -85473000
Capital expenditures: 2191000
Operating cash flow: -24262000
Depreciation & amortization: 12412000
Net tangible assets: 21783000
Owner earnings: -75252000
Return on net tangible assets (%): -345.46205756782814
Buffett classification: The Gruesome
Stock price: 7.6
Shares outstanding: 238825345
Book value: 1137050000
P/B ratio: 1.5962997423156413
Market cap (USD): 1815072622
Debt to equity: 0.10887735807572227
Current ratio: 1.6246096109604535
Quick ratio: 1.2657280193298803
Interest coverage ratio: -7.70986332949119
COGS to revenue (%): 90.35057080353695
R&D to revenue (%): 8.764270088423993
SG&A to revenue (%): 43.92245895913378
Free cash flow (dilution-adjusted): -41514000
Buyback yield (%): 5.5094214296401856e-05
Retained earnings: -621762000
Inventory turnover: 1.7600945440220603
Receivables turnover: 1.3386735572782085
Capitalized R&D asset: 15256910
ROCI (R&D-adjusted, %): -3.331576200615732
Rosenberg metric: -0.8204861562459379
FCF margin (%): -38.15835432101035
Revenue growth (%): 5.18408229561451
Rule of 40 score: -32.97427202539584
Financial ratios for RDW — annual report dated 2025-12-31
Total revenue: 335381000
Gross profit: 17285000
Operating income: -173756000
Net income: -226552000
Capital expenditures: 13479000
Operating cash flow: -177331000
Depreciation & amortization: 32639000
Net tangible assets: 21783000
Owner earnings: -207392000
Return on net tangible assets (%): -952.0818987283661
Buffett classification: The Gruesome
Stock price: 7.6
Shares outstanding: 238825345
Book value: 1137050000
P/B ratio: 1.5962997423156413
Market cap (USD): 1815072622
Debt to equity: 0.10887735807572227
Current ratio: 1.6246096109604535
Quick ratio: 1.2657280193298803
Interest coverage ratio: -4.3762845053395125
COGS to revenue (%): 94.84616003888115
R&D to revenue (%): 5.892104800212296
SG&A to revenue (%): 51.07027529883923
Free cash flow (dilution-adjusted): -259601000
Buyback yield (%): 3.5184818076111117
Retained earnings: -621762000
Inventory turnover: 5.695847583576557
Receivables turnover: 4.126750338378246
Capitalized R&D asset: 25509830
ROCI (R&D-adjusted, %): -12.45490859642465
Rosenberg metric: -4.433746736292428
FCF margin (%): -77.40480229947433
Revenue growth (%): 10.286056277355222
Rule of 40 score: -67.1187460221191
Financial ratios for REXR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.29
Shares outstanding: 222989057
Market cap (USD): 15450911759.53
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REXR — annual report dated 2022-12-31
Total revenue: 631204000
Gross profit: 480701000
Operating income: 219643000
Net income: 177157000
Capital expenditures: 135095000
Operating cash flow: 327695000
Depreciation & amortization: 196794000
Net tangible assets: 6381796000
Owner earnings: 238856000
Return on net tangible assets (%): 3.742770843818887
Capex to operating income (%): 61.506626662356645
Buffett classification: The Good
Stock price: 47.69
P/E ratio: 60.027817858340335
Shares outstanding: 222989057
Book value: 6923342000
P/B ratio: 1.5360136951677383
Market cap (USD): 10634348128.33
Debt to equity: 0.2796887688055855
Current ratio: 0.5622343125436203
Quick ratio: 0.5622343125436203
Interest coverage ratio: 4.529095183107885
COGS to revenue (%): 28.788157236012445
SG&A to revenue (%): 10.181177559077573
Free cash flow (dilution-adjusted): 164174000
Buyback yield (%): 0.020273927221325365
Retained earnings: -255743000
Receivables turnover: 6.106199998065222
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.43855213444228
FCF margin (%): 26.00965773347444
Rule of 40 score: 26.00965773347444
Financial ratios for REXR — annual report dated 2023-12-31
Total revenue: 797826000
Gross profit: 613347000
Operating income: 293810000
Net income: 249591000
Capital expenditures: 266564000
Operating cash flow: 427548000
Depreciation & amortization: 244510000
Net tangible assets: 7608091000
Owner earnings: 227537000
Return on net tangible assets (%): 2.9907239542744692
Capex to operating income (%): 90.72666008645042
Buffett classification: The Gruesome
Stock price: 50.38
P/E ratio: 45.01039176757175
Shares outstanding: 222989057
Book value: 8143905000
P/B ratio: 1.3794596930661644
Market cap (USD): 11234188691.66
Debt to equity: 0.2733226873348842
Current ratio: 0.7253551348166682
Quick ratio: 0.7253551348166682
Interest coverage ratio: 4.785179153094463
COGS to revenue (%): 26.868139168189554
SG&A to revenue (%): 9.40393018026487
Free cash flow (dilution-adjusted): 127346000
Buyback yield (%): 0.017037278369918328
Retained earnings: -338835000
Receivables turnover: 3.026619575649746
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7935664585666773
FCF margin (%): 15.961625717888362
Revenue growth (%): 26.397487975361372
Rule of 40 score: 42.35911369324973
Financial ratios for REXR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.38
Shares outstanding: 222989057
Market cap (USD): 10342232463.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REXR — annual report dated 2024-12-31
Total revenue: 936407000
Gross profit: 726147000
Operating income: 368747000
Net income: 285926000
Capital expenditures: 373392000
Operating cash flow: 478917000
Depreciation & amortization: 275247000
Net tangible assets: 8117447000
Owner earnings: 187781000
Return on net tangible assets (%): 2.3133012140393405
Capex to operating income (%): 101.25967126512217
Buffett classification: The Gruesome
Stock price: 36.03
P/E ratio: 28.099213515769815
Shares outstanding: 222989057
Book value: 8725979000
P/B ratio: 0.9207328740660504
Market cap (USD): 8034295723.71
Debt to equity: 0.3834483213860588
Current ratio: 0.8318019421460621
Quick ratio: 0.8318019421460621
Interest coverage ratio: 3.7399793095054568
COGS to revenue (%): 25.407007850218978
SG&A to revenue (%): 8.77321506567123
Free cash flow (dilution-adjusted): 63923000
Buyback yield (%): 0.02832855645683167
Retained earnings: -441881000
Receivables turnover: 3.113997253158369
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0177142700951123
FCF margin (%): 6.826412019559871
Revenue growth (%): 17.369827506248228
Rule of 40 score: 24.1962395258081
Financial ratios for REXR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.03
Shares outstanding: 222989057
Market cap (USD): 8034295723.71
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REXR — quarterly report dated 2025-03-31
Total revenue: 252287000
Gross profit: 197026000
Operating income: 90418000
Net income: 74048000
Capital expenditures: 79148000
Operating cash flow: 152551000
Depreciation & amortization: 86740000
Net tangible assets: 8615539000
Owner earnings: 81640000
Return on net tangible assets (%): 0.947590162379858
Capex to operating income (%): 87.53566767679001
Buffett classification: The Gruesome
Stock price: 36.89
P/E ratio: 27.772749813398065
Shares outstanding: 222989057
Book value: 9174746000
P/B ratio: 0.8965988064116435
Market cap (USD): 8226066312.7300005
Debt to equity: 0.36492127411483655
Current ratio: 2.0660522057271513
Quick ratio: 2.0660522057271513
Interest coverage ratio: 3.3134711228378775
COGS to revenue (%): 25.545113303499583
SG&A to revenue (%): 7.875158054120902
Free cash flow (dilution-adjusted): 63704000
Buyback yield (%): 0.01988799917000739
Retained earnings: -474550000
Receivables turnover: 0.8194488654449548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7142322816592516
FCF margin (%): 25.25060744311042
Rule of 40 score: 25.25060744311042
Financial ratios for REXR — quarterly report dated 2025-06-30
Total revenue: 249507000
Gross profit: 194209000
Operating income: 103269000
Net income: 120394000
Capital expenditures: 83196000
Operating cash flow: 128157000
Depreciation & amortization: 71188000
Net tangible assets: 8662898000
Owner earnings: 108386000
Return on net tangible assets (%): 1.2511517508344205
Capex to operating income (%): 80.56241466461378
Buffett classification: The Gruesome
Stock price: 33.92
P/E ratio: 38.89997435451189
Shares outstanding: 222989057
Book value: 9195024000
P/B ratio: 0.8225958750558999
Market cap (USD): 7563788813.440001
Debt to equity: 0.3640637588330384
Current ratio: 2.1577965047225836
Quick ratio: 2.1577965047225836
Interest coverage ratio: 3.867607954758249
COGS to revenue (%): 24.482679844653656
SG&A to revenue (%): 7.916411162813067
Free cash flow (dilution-adjusted): 34870000
Buyback yield (%): 0.0009254621159651879
Retained earnings: -462309000
Receivables turnover: 0.8047937914884558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8148774211906006
FCF margin (%): 13.975559803933358
Revenue growth (%): -1.1019196391411368
Rule of 40 score: 12.87364016479222
Financial ratios for REXR — quarterly report dated 2025-09-30
Total revenue: 253242000
Gross profit: 195363000
Operating income: 94154000
Net income: 93056000
Capital expenditures: 89152000
Operating cash flow: 149632000
Depreciation & amortization: 81172000
Net tangible assets: 8516028000
Owner earnings: 85076000
Return on net tangible assets (%): 0.9990103367438435
Capex to operating income (%): 94.68742698132846
Buffett classification: The Gruesome
Stock price: 39.61
P/E ratio: 30.72228866903422
Shares outstanding: 222989057
Book value: 9042359000
P/B ratio: 0.9768022423982502
Market cap (USD): 8832596547.77
Debt to equity: 0.3593899556520594
Current ratio: 1.462121909672667
Quick ratio: 1.462121909672667
Interest coverage ratio: 3.6976789851942033
COGS to revenue (%): 24.929908940854993
SG&A to revenue (%): 7.912194659653612
Free cash flow (dilution-adjusted): 48551000
Buyback yield (%): 1.6997153576306352
Retained earnings: -474813000
Receivables turnover: 0.7895184798366355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7582920525348832
FCF margin (%): 19.171780352390204
Revenue growth (%): 1.496951989322945
Rule of 40 score: 20.66873234171315
Financial ratios for REXR — quarterly report dated 2025-12-31
Total revenue: 248097000
Gross profit: 188810000
Operating income: 92792000
Net income: -65423000
Capital expenditures: 81928000
Operating cash flow: 111745000
Depreciation & amortization: 76819000
Net tangible assets: 8314780000
Owner earnings: -70532000
Return on net tangible assets (%): -0.8482725941035121
Capex to operating income (%): 88.29209414604708
Buffett classification: The Gruesome
Stock price: 37.72
P/E ratio: 37.875254891545644
Shares outstanding: 222989057
Book value: 8838019000
P/B ratio: 0.9517005145655377
Market cap (USD): 8411147230.04
Debt to equity: 0.36794546379680787
Current ratio: 1.21788842056976
Quick ratio: 1.21788842056976
Interest coverage ratio: 3.645907822875329
COGS to revenue (%): 25.56097010443496
SG&A to revenue (%): 7.738505503895654
Free cash flow (dilution-adjusted): -38944000
Buyback yield (%): 1.1903370284902726
Retained earnings: -642130000
Receivables turnover: 0.7563056719038648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7601388159358492
FCF margin (%): -15.697086220308993
Revenue growth (%): -2.031653517189092
Rule of 40 score: -17.728739737498085
Financial ratios for REXR — annual report dated 2025-12-31
Total revenue: 1003133000
Gross profit: 775408000
Operating income: 380633000
Net income: 219763000
Capital expenditures: 333424000
Operating cash flow: 542085000
Depreciation & amortization: 315919000
Net tangible assets: 8314780000
Owner earnings: 202258000
Return on net tangible assets (%): 2.432511744147169
Capex to operating income (%): 87.59723933552792
Buffett classification: The Gruesome
Stock price: 37.72
P/E ratio: 38.273718642537645
Shares outstanding: 222989057
Book value: 8838019000
P/B ratio: 0.9517005145655377
Market cap (USD): 8411147230.04
Debt to equity: 0.36794546379680787
Current ratio: 1.21788842056976
Quick ratio: 1.21788842056976
Interest coverage ratio: 3.628428166973299
COGS to revenue (%): 25.129469372456093
SG&A to revenue (%): 7.860971576052228
Free cash flow (dilution-adjusted): 108181000
Buyback yield (%): 2.9955010072841373
Retained earnings: -642130000
Receivables turnover: 3.057978039129613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1180911924100148
FCF margin (%): 10.784312748160014
Revenue growth (%): 7.125747671685495
Rule of 40 score: 17.910060419845507
Financial ratios for RSKD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.86
Shares outstanding: 93613888
Market cap (USD): 735805159.6800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RSKD — annual report dated 2022-12-31
Total revenue: 261247000
Gross profit: 135097000
Operating income: -109348000
Net income: -104705000
Capital expenditures: 6126000
Operating cash flow: -26252000
Depreciation & amortization: 4274000
Net tangible assets: 494436000
Owner earnings: -106557000
Return on net tangible assets (%): -21.551221998398177
Buffett classification: The Gruesome
Stock price: 4.62
Shares outstanding: 93613888
Book value: 494436000
P/B ratio: 0.8747262791544305
Market cap (USD): 432496162.56
Debt to equity: 0.07567410140038347
Current ratio: 7.298173855561064
Quick ratio: 7.298173855561064
COGS to revenue (%): 48.28763583888044
R&D to revenue (%): 27.565484005557963
SG&A to revenue (%): 66.00305458053107
Free cash flow (dilution-adjusted): -101731000
Buyback yield (%): 0
Retained earnings: -352534000
Receivables turnover: 6.957866141103151
Capitalized R&D asset: 72014000
ROCI (R&D-adjusted, %): -10.11544901542362
FCF margin (%): -38.94054285790842
Rule of 40 score: -38.94054285790842
Financial ratios for RSKD — annual report dated 2023-12-31
Total revenue: 297610000
Gross profit: 152519000
Operating income: -76849000
Net income: -59035000
Capital expenditures: 1355000
Operating cash flow: 7279000
Depreciation & amortization: 5100000
Net tangible assets: 491721000
Owner earnings: -55290000
Return on net tangible assets (%): -11.244181151506647
Buffett classification: The Gruesome
Stock price: 4.68
Shares outstanding: 93613888
Book value: 491721000
P/B ratio: 0.8909788189644128
Market cap (USD): 438112995.84
Debt to equity: 0.06367228570673207
Current ratio: 7.624858546647377
Quick ratio: 7.624858546647377
COGS to revenue (%): 48.7520580625651
R&D to revenue (%): 24.050603138335404
SG&A to revenue (%): 52.41188132119217
Free cash flow (dilution-adjusted): -56486000
Buyback yield (%): 3.0026500297663485
Retained earnings: -411569000
Receivables turnover: 6.347523781086038
Capitalized R&D asset: 119826380
ROCI (R&D-adjusted, %): -8.150299900993032
Rosenberg metric: 0.2419251812147638
FCF margin (%): -18.97987298813884
Revenue growth (%): 13.91901151018002
Rule of 40 score: -5.06086147795882
Financial ratios for RSKD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.73
Shares outstanding: 93613888
Market cap (USD): 442793690.24000007
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RSKD — annual report dated 2024-12-31
Total revenue: 327516000
Gross profit: 170939000
Operating income: -47852000
Net income: -34922000
Capital expenditures: 546000
Operating cash flow: 39696000
Depreciation & amortization: 4881000
Net tangible assets: 382304000
Owner earnings: -30587000
Return on net tangible assets (%): -8.000701012806562
Buffett classification: The Gruesome
Stock price: 4.73
Shares outstanding: 93613888
Book value: 382304000
P/B ratio: 1.1582240579224912
Market cap (USD): 442793690.24000007
Debt to equity: 0.07201075583828576
Current ratio: 6.148315116460398
Quick ratio: 6.148315116460398
COGS to revenue (%): 47.80743536193652
R&D to revenue (%): 20.782190793732212
SG&A to revenue (%): 45.494876586182045
Free cash flow (dilution-adjusted): -18772000
Buyback yield (%): 31.858629223812844
Retained earnings: -446491000
Receivables turnover: 6.8513691609313225
Capitalized R&D asset: 139786210
ROCI (R&D-adjusted, %): -8.907851471490744
Rosenberg metric: 0.2573452365983486
FCF margin (%): -5.7316283784609
Revenue growth (%): 10.048721481133025
Rule of 40 score: 4.317093102672126
Financial ratios for RSKD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.73
Shares outstanding: 93613888
Market cap (USD): 442793690.24000007
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RSKD — quarterly report dated 2025-03-31
Total revenue: 82387000
Gross profit: 40454000
Operating income: -17058000
Net income: -13886000
Capital expenditures: 192000
Operating cash flow: 3844000
Depreciation & amortization: 956000
Net tangible assets: 359326000
Owner earnings: -13122000
Return on net tangible assets (%): -3.6518370504778392
Buffett classification: The Gruesome
Stock price: 4.62
Shares outstanding: 93613888
Book value: 359326000
P/B ratio: 1.2036316953407213
Market cap (USD): 432496162.56
Debt to equity: 0.07264433968040164
Current ratio: 6.957437915781408
Quick ratio: 6.957437915781408
COGS to revenue (%): 50.897593066867344
R&D to revenue (%): 21.94156845133334
SG&A to revenue (%): 47.865561314285024
Free cash flow (dilution-adjusted): -10680000
Buyback yield (%): 4.78293261090617
Retained earnings: -460377000
Receivables turnover: 2.5646557091271323
Capitalized R&D asset: 18077000
ROCI (R&D-adjusted, %): -1.1908782846278387
FCF margin (%): -12.963210215203855
Rule of 40 score: -12.963210215203855
Financial ratios for RSKD — quarterly report dated 2025-06-30
Total revenue: 81060000
Gross profit: 39750000
Operating income: -13006000
Net income: -11633000
Capital expenditures: 240000
Operating cash flow: 5592000
Depreciation & amortization: 875000
Net tangible assets: 338425000
Owner earnings: -10998000
Return on net tangible assets (%): -3.2497599172637956
Buffett classification: The Gruesome
Stock price: 4.99
Shares outstanding: 93613888
Book value: 338425000
P/B ratio: 1.3803155828322375
Market cap (USD): 467133301.12
Debt to equity: 0.07846347048829135
Current ratio: 6.244882156511639
Quick ratio: 6.244882156511639
COGS to revenue (%): 50.962250185048106
R&D to revenue (%): 21.17813964964224
SG&A to revenue (%): 43.90451517394523
Free cash flow (dilution-adjusted): -7519000
Buyback yield (%): 4.980377109535924
Retained earnings: -472010000
Receivables turnover: 2.4294919826165144
Capitalized R&D asset: 29278590
ROCI (R&D-adjusted, %): -1.83803582941603
Rosenberg metric: -0.03894451512972285
FCF margin (%): -9.275845053047126
Revenue growth (%): -1.6106910070763591
Rule of 40 score: -10.886536060123486
Financial ratios for RSKD — quarterly report dated 2025-09-30
Total revenue: 81862000
Gross profit: 41063000
Operating income: -8951000
Net income: -7806000
Capital expenditures: 110000
Operating cash flow: 13505000
Depreciation & amortization: 862000
Net tangible assets: 316296000
Owner earnings: -7054000
Return on net tangible assets (%): -2.2301894428004148
Buffett classification: The Gruesome
Stock price: 4.68
Shares outstanding: 93613888
Book value: 316296000
P/B ratio: 1.3851360619166857
Market cap (USD): 438112995.84
Debt to equity: 0.08117396362900574
Current ratio: 6.042761964444738
Quick ratio: 6.042761964444738
COGS to revenue (%): 49.83875302338081
R&D to revenue (%): 20.773985487772105
SG&A to revenue (%): 40.32151669883463
Free cash flow (dilution-adjusted): 440000
Buyback yield (%): 5.764038099710345
Retained earnings: -479816000
Receivables turnover: 2.653635450095627
Capitalized R&D asset: 34473300
ROCI (R&D-adjusted, %): -2.3668526354653383
Rosenberg metric: 0.07648395176792684
FCF margin (%): 0.5374899220639613
Revenue growth (%): 0.9893905748828029
Rule of 40 score: 1.5268804969467642
Financial ratios for RSKD — annual report dated 2025-12-31
Total revenue: 344638000
Gross profit: 178072000
Operating income: -34035000
Net income: -27565000
Capital expenditures: 760000
Operating cash flow: 33879000
Depreciation & amortization: 3547000
Net tangible assets: 294759000
Owner earnings: -24778000
Return on net tangible assets (%): -8.406189463256423
Buffett classification: The Gruesome
Stock price: 4.97
Shares outstanding: 93613888
Book value: 294759000
P/B ratio: 1.5784455211206443
Market cap (USD): 465261023.35999995
Debt to equity: 0.08488968954298257
Current ratio: 5.031928733031674
Quick ratio: 5.031928733031674
COGS to revenue (%): 48.33071222558162
R&D to revenue (%): 20.14084343572096
SG&A to revenue (%): 41.0253657460872
Free cash flow (dilution-adjusted): -18557000
Buyback yield (%): 22.83191470303007
Retained earnings: -474056000
Receivables turnover: 7.11283099085712
Capitalized R&D asset: 138636960
ROCI (R&D-adjusted, %): -7.169877377896823
Rosenberg metric: 0.10479688533019907
FCF margin (%): -5.3844903928179715
Revenue growth (%): 5.227836197315551
Rule of 40 score: -0.1566541955024201
Financial ratios for RSKD — quarterly report dated 2025-12-31
Total revenue: 99329000
Gross profit: 56805000
Operating income: 4980000
Net income: 5760000
Capital expenditures: 218000
Operating cash flow: 10938000
Depreciation & amortization: 854000
Net tangible assets: 294759000
Owner earnings: 6396000
Return on net tangible assets (%): 2.1699082979654563
Capex to operating income (%): 4.377510040160643
Buffett classification: The Great
Stock price: 4.97
P/E ratio: 20.193620805555554
Shares outstanding: 93613888
Book value: 294759000
P/B ratio: 1.5784455211206443
Market cap (USD): 465261023.35999995
Debt to equity: 0.08488968954298257
Current ratio: 5.031928733031674
Quick ratio: 5.031928733031674
Effective tax rate (%): 19.944405837387073
COGS to revenue (%): 42.81126357861249
R&D to revenue (%): 17.278941698798942
SG&A to revenue (%): 33.58233748452113
Free cash flow (dilution-adjusted): -798000
Buyback yield (%): 7.957683567091401
Retained earnings: -474056000
Receivables turnover: 2.050007223494933
Capitalized R&D asset: 34222130
ROCI (R&D-adjusted, %): 1.3449241863482684
Rosenberg metric: 0.925673291779372
FCF margin (%): -0.8033907519455546
Revenue growth (%): 21.337128337934573
Rule of 40 score: 20.53373758598902
Financial ratios for SAILIFE.NS — quarterly report dated 2024-12-31
Total revenue: 51262151.765940085
Gross profit: 21682363.91187784
Operating income: 9984846.718731787
Net income: 6277071.919804173
Capital expenditures: 0
Depreciation & amortization: 3974006.294439911
Owner earnings: 10251078.214244083
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.756265298985896
P/E ratio: 74.03573791535905
Shares outstanding: 212294916
Market cap (USD): 1858910606.1219258
Effective tax rate (%): 24.839493077266635
Interest coverage ratio: 3.703895879275306
COGS to revenue (%): 57.70297741133026
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAILIFE.NS — quarterly report dated 2025-03-31
Total revenue: 67746902.03413607
Gross profit: 30475800.79494973
Operating income: 14038461.538461538
Net income: 10319032.031797988
Capital expenditures: 0
Depreciation & amortization: 4382511.105915361
Net tangible assets: 247544891.27893382
Owner earnings: 14701543.13771335
Return on net tangible assets (%): 5.938940230904477
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.879099078072121
P/E ratio: 45.66774255391468
Shares outstanding: 212294916
Book value: 248814005.1437924
P/B ratio: 7.57589023915934
Market cap (USD): 1884987592.9349985
Debt to equity: 0.16556495509442734
Current ratio: 2.053967972259007
Quick ratio: 1.8916927193545308
Effective tax rate (%): 25.697618626733
Interest coverage ratio: 11.030127675208965
COGS to revenue (%): 55.01521120538665
Buyback yield (%): 0
Retained earnings: 84697100.77156885
Inventory turnover: 2.6821772599167124
Receivables turnover: 1.6334125366773493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.9468894761450635
Revenue growth (%): 32.1577415311483
Rule of 40 score: 32.1577415311483
Financial ratios for SAILIFE.NS — annual report dated 2025-03-31
Total revenue: 198102642.03881225
Gross profit: 79458498.94786064
Operating income: 31223754.968435816
Net income: 19889174.6551321
Capital expenditures: 43114683.18915127
Operating cash flow: 36713233.5749357
Depreciation & amortization: 16199789.572129996
Net tangible assets: 247544891.27893382
Owner earnings: -7025718.961889178
Return on net tangible assets (%): -2.8381595457660205
Capex to operating income (%): 138.0829539327862
Buffett classification: The Gruesome
Stock price: 8.879099078072121
P/E ratio: 94.77455076038594
Shares outstanding: 212294916
Book value: 248814005.1437924
P/B ratio: 7.57589023915934
Market cap (USD): 1884987592.9349985
Debt to equity: 0.16556495509442734
Current ratio: 2.053967972259007
Quick ratio: 1.8916927193545308
Effective tax rate (%): 25.28337351725713
Interest coverage ratio: 3.5067485951368096
COGS to revenue (%): 59.89023764140755
SG&A to revenue (%): 2.769611169795287
Free cash flow (dilution-adjusted): -6746902.0341360755
Buyback yield (%): 0
Retained earnings: 84697100.77156885
Inventory turnover: 8.538106254995162
Receivables turnover: 4.776356251567861
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.002663250236354
FCF margin (%): -3.40576075346548
Revenue growth (%): 13.423409473703918
Rule of 40 score: 10.017648720238437
Financial ratios for SAILIFE.NS — quarterly report dated 2025-06-30
Total revenue: 58087877.36952961
Gross profit: 22781184.17973321
Operating income: 9736484.905218817
Net income: 7074069.740229348
Capital expenditures: 0
Depreciation & amortization: 4414228.879007723
Owner earnings: 11488298.61923707
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.051018020126376
P/E ratio: 81.1774824854924
Shares outstanding: 212294916
Market cap (USD): 1921485110.2972152
Effective tax rate (%): 25.13127260117897
Interest coverage ratio: 6.729860886444517
COGS to revenue (%): 60.78151722637529
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -14.257514918895486
Rule of 40 score: -14.257514918895486
Financial ratios for SAILIFE.NS — quarterly report dated 2025-12-31
Total revenue: 61987746.46318369
Gross profit: 28464409.045338087
Operating income: 16016263.78522892
Net income: 11181352.344881363
Capital expenditures: 0
Depreciation & amortization: 4909769.410716275
Owner earnings: 16091121.755597638
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.11919349448591
P/E ratio: 61.6401511554084
Shares outstanding: 212294916
Market cap (USD): 2148253332.8996325
Effective tax rate (%): 25.185963656962272
Interest coverage ratio: 14.824002474481906
COGS to revenue (%): 54.08058742344518
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 6.71374006119181
Rule of 40 score: 6.71374006119181
Financial ratios for SNS.AX — annual report dated 2021-06-30
Total revenue: 4159802.2556390977
Gross profit: 2633752.6315789474
Operating income: -4662348.872180451
Net income: -2271990.22556391
Capital expenditures: 189890.22556390977
Depreciation & amortization: 416409.02255639096
Net tangible assets: 3763448.1203007516
Owner earnings: -2045471.4285714286
Return on net tangible assets (%): -54.35099311022168
Buffett classification: The Gruesome
Stock price: 0.10526315789473685
Shares outstanding: 829932335
Book value: 4740941.353383459
P/B ratio: 18.426994115568558
Market cap (USD): 87361298.42105263
Debt to equity: 0.20697453568752877
Current ratio: 2.2038564647406504
Quick ratio: 2.1110954819262213
Interest coverage ratio: -34.16788256816027
COGS to revenue (%): 36.68562903420257
R&D to revenue (%): 64.57278098637208
SG&A to revenue (%): 45.699576884890234
Free cash flow (dilution-adjusted): -2753030.07518797
Buyback yield (%): 0.09252045142416855
Retained earnings: -29279481.203007516
Inventory turnover: 6.011236753721397
Receivables turnover: 5.529832911706176
Capitalized R&D asset: 2686100
ROCI (R&D-adjusted, %): -37.731867349622675
FCF margin (%): -66.18175350657393
Rule of 40 score: -66.18175350657393
Financial ratios for SNS.AX — annual report dated 2022-06-30
Total revenue: 6307188.275862069
Gross profit: 3884546.896551724
Operating income: -10747003.448275862
Net income: -8327697.24137931
Capital expenditures: 175169.6551724138
Depreciation & amortization: 491504.8275862069
Net tangible assets: 2783277.931034483
Owner earnings: -8011362.068965518
Return on net tangible assets (%): -287.8390971895455
Buffett classification: The Gruesome
Stock price: 0.048275862068965524
Shares outstanding: 829932335
Book value: 8494566.206896551
P/B ratio: 4.7166268359302475
Market cap (USD): 40065698.93103449
Debt to equity: 0.1885691469621838
Current ratio: 1.4240510878687187
Quick ratio: 1.3950740091267981
Interest coverage ratio: -59.38521310325904
COGS to revenue (%): 38.41079849450376
SG&A to revenue (%): 167.85879668988522
Free cash flow (dilution-adjusted): -5614660.689655173
Buyback yield (%): 0.6060321945230803
Retained earnings: -35184048.965517245
Inventory turnover: 15.1552267138358
Receivables turnover: 4.479355022302679
Capitalized R&D asset: 1799687
ROCI (R&D-adjusted, %): -111.59015326661917
Rosenberg metric: 0.46565439297597877
FCF margin (%): -89.02002673905844
Revenue growth (%): 51.622310106494574
Rule of 40 score: -37.39771663256386
Financial ratios for SNS.AX — annual report dated 2023-06-30
Total revenue: 2464164.9006622517
Gross profit: 269463.5761589404
Operating income: -10617609.27152318
Net income: -4906744.370860927
Capital expenditures: 100010.59602649006
Depreciation & amortization: 976590.0662251655
Net tangible assets: -956418.5430463576
Owner earnings: -4030164.9006622513
Buffett classification: The Gruesome
Stock price: 0.033112582781456956
Shares outstanding: 829932335
Book value: 3892468.8741721855
P/B ratio: 7.060095798849469
Market cap (USD): 27481203.145695366
Debt to equity: 0.762063369781143
Current ratio: 0.7866417820774602
Quick ratio: 0.7342011486540395
Interest coverage ratio: -34.08774208911559
COGS to revenue (%): 89.0647100733185
SG&A to revenue (%): 275.78202413455494
Free cash flow (dilution-adjusted): -3268363.5761589403
Buyback yield (%): 0
Retained earnings: -38692751.655629136
Inventory turnover: 6.822704336350778
Receivables turnover: 2.1585261716778534
Capitalized R&D asset: 886413
ROCI (R&D-adjusted, %): -206.60662750470996
FCF margin (%): -132.6357491448952
Revenue growth (%): -60.9308491694669
Rule of 40 score: -193.5665983143621
Financial ratios for SOL.AX — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.15555555555555
Shares outstanding: 379919682
Market cap (USD): 8037411939.199999
Buyback yield (%): 0.06704756368908062
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOL.AX — annual report dated 2022-07-31
Total revenue: 1786664335.6643357
Gross profit: 1082627972.027972
Operating income: 819551748.2517483
Net income: 389121678.32167834
Capital expenditures: 93787412.5874126
Depreciation & amortization: 108623076.92307693
Net tangible assets: 5805029370.629371
Owner earnings: 403957342.6573427
Return on net tangible assets (%): 6.958747611186442
Capex to operating income (%): 11.443745045688459
Buffett classification: The Great
Stock price: 16.055944055944057
P/E ratio: 15.676251156845973
Shares outstanding: 379919682
Book value: 9598505594.405594
P/B ratio: 0.6355123826254131
Market cap (USD): 6099969159.9440565
Debt to equity: 0.0623261357045455
Current ratio: 5.281238814873732
Quick ratio: 4.968631934778286
Effective tax rate (%): 60.82622091159383
Interest coverage ratio: 31.35172948824269
COGS to revenue (%): 39.40507176321856
SG&A to revenue (%): 8.052940785070433
Free cash flow (dilution-adjusted): 605110489.5104896
Buyback yield (%): 0
Retained earnings: 2764332167.832168
Inventory turnover: 8.004993321035558
Receivables turnover: 30.759682642876925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.781647047199863
FCF margin (%): 33.86816859953111
Rule of 40 score: 33.86816859953111
Financial ratios for SOL.AX — annual report dated 2023-07-31
Total revenue: 240662000
Gross profit: 84579333.33333333
Operating income: -57936666.666666664
Net income: 460480000
Capital expenditures: 102878000
Depreciation & amortization: 27794000
Net tangible assets: 5641476000
Owner earnings: 385396000
Return on net tangible assets (%): 6.831474599909669
Buffett classification: The Gruesome
Stock price: 20.273333333333333
P/E ratio: 16.726542636118833
Shares outstanding: 379919682
Book value: 6369340000
P/B ratio: 1.2092678916622446
Market cap (USD): 7702238353.08
Debt to equity: 0.082103116911119
Current ratio: 4.167323563323017
Quick ratio: 4.052624552460708
Effective tax rate (%): 2.4466731918731854
Interest coverage ratio: -4.294149619527621
COGS to revenue (%): 64.85555121567454
SG&A to revenue (%): 44.28423819852462
Free cash flow (dilution-adjusted): 390819333.3333333
Buyback yield (%): 0
Retained earnings: 2905718000
Inventory turnover: 3.0966735004298656
Receivables turnover: 1.4266637157999156
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8373371128562391
FCF margin (%): 162.3934536126739
Revenue growth (%): -86.53009436657756
Rule of 40 score: 75.86335924609635
Financial ratios for SOL.AX — annual report dated 2024-07-31
Total revenue: 385294117.64705884
Gross profit: 121895424.8366013
Operating income: -90522875.81699346
Net income: 326013071.89542484
Capital expenditures: 112026143.79084967
Depreciation & amortization: 40000000
Net tangible assets: 5690000000
Owner earnings: 253986928.10457516
Return on net tangible assets (%): 4.463742145950354
Buffett classification: The Gruesome
Stock price: 21.999999999999996
P/E ratio: 25.637723528708896
Shares outstanding: 379919682
Book value: 5881568627.45098
P/B ratio: 1.42108908922523
Market cap (USD): 8358233003.999999
Debt to equity: 0.0851113481797573
Current ratio: 3.3127677806341045
Quick ratio: 3.0414167380748354
Effective tax rate (%): -5.418614534636634
Interest coverage ratio: -3.7841530054644807
COGS to revenue (%): 68.36301950805766
SG&A to revenue (%): 40.71246819338422
Free cash flow (dilution-adjusted): 167124183.00653595
Buyback yield (%): 0
Retained earnings: 2984248366.013072
Inventory turnover: 4.242105263157894
Receivables turnover: 0.7818302387267906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.378438632111151
FCF margin (%): 43.375742154368105
Revenue growth (%): 60.097613103464134
Rule of 40 score: 103.47335525783224
Financial ratios for SPANDANA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.376895687722537
Shares outstanding: 71305144
Market cap (USD): 312095177.2860345
Buyback yield (%): 0
Retained earnings: 37144270.077805616
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPANDANA.NS — annual report dated 2023-03-31
Total revenue: 154447015.83434838
Gross profit: 67230207.06455542
Operating income: 49808769.792935446
Net income: 1509135.2009744216
Capital expenditures: 1551766.138855055
Operating cash flow: -264439707.67356884
Depreciation & amortization: 1323995.1278928136
Net tangible assets: 374780755.1766139
Owner earnings: 1281364.1900121802
Return on net tangible assets (%): 0.3418970084011764
Capex to operating income (%): 3.1154476316239945
Buffett classification: The Great
Stock price: 6.4902557856272844
P/E ratio: 306.6581596481033
Shares outstanding: 71305144
Book value: 377496954.93300843
P/B ratio: 1.2259400171138184
Market cap (USD): 462788623.3909866
Debt to equity: 1.959916108735985
Current ratio: 1.3339027677285578
Quick ratio: 1.3336091892379212
Effective tax rate (%): 30.47138047138047
Interest coverage ratio: 417.2755102040816
COGS to revenue (%): 56.47037483931514
SG&A to revenue (%): 2.0646524869677685
Free cash flow (dilution-adjusted): -269506699.14738125
Buyback yield (%): 0
Retained earnings: 35352009.74421438
Inventory turnover: 563.8188976377953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.086926600061702
FCF margin (%): -174.4978351905742
Rule of 40 score: -174.4978351905742
Financial ratios for SPANDANA.NS — annual report dated 2024-03-31
Total revenue: 265718911.14042452
Gross profit: 105905983.93092696
Operating income: 78743254.58688092
Net income: 60045569.01307111
Capital expenditures: 3079505.935963545
Operating cash flow: -321221969.0610385
Depreciation & amortization: 2447535.6757404963
Net tangible assets: 434369828.5166087
Owner earnings: 59413598.75284806
Return on net tangible assets (%): 13.678113637806751
Capex to operating income (%): 3.9108187134502925
Buffett classification: The Great
Stock price: 10.083373320537428
P/E ratio: 11.974178918517095
Shares outstanding: 71305144
Book value: 437089579.0862212
P/B ratio: 1.6449634606476142
Market cap (USD): 718996386.6266794
Debt to equity: 2.5857049183925995
Current ratio: 1.4485660657915584
Quick ratio: 1.4485660657915584
Effective tax rate (%): 25.329197548354387
Interest coverage ratio: 501.25190839694653
COGS to revenue (%): 60.14360307424306
SG&A to revenue (%): 1.041144853170144
Free cash flow (dilution-adjusted): -327472118.9591078
Buyback yield (%): 0
Retained earnings: 82412759.32365991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.62988926155304
FCF margin (%): -123.24005000383605
Revenue growth (%): 72.0453514138599
Rule of 40 score: -51.19469858997614
Financial ratios for SPANDANA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 416301958.91065454
Buffett classification: The Gruesome
Stock price: 6.989966555183947
Shares outstanding: 71305144
Book value: 418890348.78165317
P/B ratio: 1.1898592870956244
Market cap (USD): 498420571.77257526
Debt to equity: 2.2381100386375623
Current ratio: 1968.5474060822896
Quick ratio: 1968.5474060822896
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPANDANA.NS — quarterly report dated 2024-12-31
Total revenue: 58622217.041613236
Gross profit: 10514045.926098611
Operating income: 1032754.4002797528
Net income: -51311341.64821074
Capital expenditures: 0
Depreciation & amortization: 657419.2796363212
Owner earnings: -50653922.36857442
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.858258538291176
Shares outstanding: 71305144
Market cap (USD): 275113680.6620818
COGS to revenue (%): 82.06474190726159
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPANDANA.NS — annual report dated 2025-03-31
Total revenue: 256525602.05751693
Gross profit: 73683656.76876314
Operating income: 44161795.65115735
Net income: -121007715.68856674
Capital expenditures: 2561374.7954173484
Operating cash flow: 430361234.51017064
Depreciation & amortization: 2654898.2931961655
Net tangible assets: 305433715.22094923
Owner earnings: -120914192.19078793
Return on net tangible assets (%): -39.58770304821103
Capex to operating income (%): 5.799978822532825
Buffett classification: The Great
Stock price: 2.7424436923795077
Shares outstanding: 71305144
Book value: 307841945.28875375
P/B ratio: 0.6352296864989841
Market cap (USD): 195550342.3970125
Debt to equity: 2.14774729614777
Current ratio: 1.5551044178110114
Quick ratio: 1.5551044178110114
Interest coverage ratio: 281.910447761194
COGS to revenue (%): 71.27629516205477
SG&A to revenue (%): 1.4063582339859273
Free cash flow (dilution-adjusted): 425519055.41267246
Buyback yield (%): 0
Retained earnings: -40617255.08534019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.992829732329053
FCF margin (%): 165.8778118050239
Revenue growth (%): -3.459787278011687
Rule of 40 score: 162.41802452701222